Overall  ||| S:0 E:8 ||| JJ
survival  ||| S:8 E:17 ||| NN
in  ||| S:17 E:20 ||| IN
patients  ||| S:20 E:29 ||| NNS
with  ||| S:29 E:34 ||| IN
a  ||| S:34 E:36 ||| DT
re-excision  ||| S:36 E:48 ||| JJ
following  ||| S:48 E:58 ||| JJ
breast  ||| S:58 E:65 ||| NN
conserving  ||| S:65 E:76 ||| NN
surgery  ||| S:76 E:84 ||| NN
compared  ||| S:84 E:93 ||| VBN
to  ||| S:93 E:96 ||| TO
those  ||| S:96 E:102 ||| DT
without  ||| S:102 E:110 ||| NN
in  ||| S:110 E:113 ||| IN
a  ||| S:113 E:115 ||| DT
large  ||| S:115 E:121 ||| JJ
population-based  ||| S:121 E:138 ||| JJ
cohort  ||| S:138 E:145 ||| NN
To  ||| S:145 E:148 ||| TO
investigate  ||| S:148 E:160 ||| VB
the  ||| S:160 E:164 ||| DT
overall  ||| S:164 E:172 ||| JJ
survival  ||| S:172 E:181 ||| NN
of  ||| S:181 E:184 ||| IN
invasive  ||| S:184 E:193 ||| JJ
breast  ||| S:193 E:200 ||| NN
cancer  ||| S:200 E:207 ||| NN
patients  ||| S:207 E:216 ||| NNS
with  ||| S:216 E:221 ||| IN
primary  ||| S:221 E:229 ||| JJ
breast  ||| S:229 E:236 ||| NN
conserving  ||| S:236 E:247 ||| NN
surgery  ||| S:247 E:255 ||| NN
( ||| S:255 E:256 ||| -LRB-
BCS ||| S:256 E:259 ||| NNP
)  ||| S:259 E:261 ||| -RRB-
followed  ||| S:261 E:270 ||| VBD
by  ||| S:270 E:273 ||| IN
re-excision  ||| S:273 E:285 ||| JJ
compared  ||| S:285 E:294 ||| VBN
to  ||| S:294 E:297 ||| TO
those  ||| S:297 E:303 ||| DT
with  ||| S:303 E:308 ||| IN
primary  ||| S:308 E:316 ||| JJ
BCS  ||| S:316 E:320 ||| NNP
only ||| S:320 E:324 ||| RB
.  ||| S:324 E:326 ||| .
The  ||| S:326 E:330 ||| DT
Dutch  ||| S:330 E:336 ||| JJ
re-excision  ||| S:336 E:348 ||| JJ
indications  ||| S:348 E:360 ||| NNS
are  ||| S:360 E:364 ||| VBP
less  ||| S:364 E:369 ||| RBR
stringent  ||| S:369 E:379 ||| JJ
compared  ||| S:379 E:388 ||| VBN
to  ||| S:388 E:391 ||| TO
other  ||| S:391 E:397 ||| JJ
European  ||| S:397 E:406 ||| JJ
and  ||| S:406 E:410 ||| CC
Northern  ||| S:410 E:419 ||| NNP
American  ||| S:419 E:428 ||| NNP
countries  ||| S:428 E:438 ||| NNS
( ||| S:438 E:439 ||| -LRB-
Society  ||| S:439 E:447 ||| NNP
of  ||| S:447 E:450 ||| IN
Surgical  ||| S:450 E:459 ||| NNP
Oncology-American  ||| S:459 E:477 ||| NNP
Society  ||| S:477 E:485 ||| NNP
for  ||| S:485 E:489 ||| IN
Radiation  ||| S:489 E:499 ||| NNP
Oncology  ||| S:499 E:508 ||| NNP
( ||| S:508 E:509 ||| -LRB-
SSO ||| S:509 E:512 ||| NNP
/ ||| S:512 E:513 ||| NNP
ASTRO ||| S:513 E:518 ||| NNP
)  ||| S:518 E:520 ||| -RRB-
guideline ||| S:520 E:529 ||| NN
) ||| S:529 E:530 ||| -RRB-
.  ||| S:530 E:532 ||| .
Retrospective  ||| S:532 E:546 ||| JJ
analyses  ||| S:546 E:555 ||| NNS
in  ||| S:555 E:558 ||| IN
women  ||| S:558 E:564 ||| NNS
< ||| S:564 E:565 ||| SYM
75years  ||| S:565 E:573 ||| VBP
with  ||| S:573 E:578 ||| IN
breast  ||| S:578 E:585 ||| JJ
cancer  ||| S:585 E:592 ||| NN
stage  ||| S:592 E:598 ||| NN
pT1-T3  ||| S:598 E:605 ||| VBZ
treated  ||| S:605 E:613 ||| VBN
by  ||| S:613 E:616 ||| IN
BCS  ||| S:616 E:620 ||| NNP
and  ||| S:620 E:624 ||| CC
radiotherapy  ||| S:624 E:637 ||| NN
between  ||| S:637 E:645 ||| IN
1999  ||| S:645 E:650 ||| CD
and  ||| S:650 E:654 ||| CC
2012  ||| S:654 E:659 ||| CD
from  ||| S:659 E:664 ||| IN
a  ||| S:664 E:666 ||| DT
population-based  ||| S:666 E:683 ||| JJ
database ||| S:683 E:691 ||| NN
.  ||| S:691 E:693 ||| .
The  ||| S:693 E:697 ||| DT
national  ||| S:697 E:706 ||| JJ
guideline  ||| S:706 E:716 ||| NN
recommends  ||| S:716 E:727 ||| VBZ
to  ||| S:727 E:730 ||| TO
reserve  ||| S:730 E:738 ||| VB
re-excision  ||| S:738 E:750 ||| JJ
for  ||| S:750 E:754 ||| IN
invasive  ||| S:754 E:763 ||| JJ
tumours  ||| S:763 E:771 ||| JJ
showing  ||| S:771 E:779 ||| NN
' ||| S:779 E:780 ||| POS
more  ||| S:780 E:785 ||| JJR
than  ||| S:785 E:790 ||| IN
focally  ||| S:790 E:798 ||| JJ
positive ||| S:798 E:806 ||| NN
'  ||| S:806 E:808 ||| POS
margin  ||| S:808 E:815 ||| NN
since  ||| S:815 E:821 ||| IN
2002 ||| S:821 E:825 ||| CD
.  ||| S:825 E:827 ||| .
Patients  ||| S:827 E:836 ||| NNS
were  ||| S:836 E:841 ||| VBD
divided  ||| S:841 E:849 ||| VBN
into  ||| S:849 E:854 ||| IN
' ||| S:854 E:855 ||| POS
primary  ||| S:855 E:863 ||| JJ
BCS  ||| S:863 E:867 ||| NNP
only ||| S:867 E:871 ||| RB
' ||| S:871 E:872 ||| POS
,  ||| S:872 E:874 ||| ,
' ||| S:874 E:875 ||| ''
re-excision  ||| S:875 E:887 ||| JJ
by  ||| S:887 E:890 ||| IN
BCS ||| S:890 E:893 ||| NNP
' ||| S:893 E:894 ||| POS
,  ||| S:894 E:896 ||| ,
and  ||| S:896 E:900 ||| NNP
' ||| S:900 E:901 ||| POS
re-excision  ||| S:901 E:913 ||| JJ
by  ||| S:913 E:916 ||| IN
mastectomy ||| S:916 E:926 ||| NN
' ||| S:926 E:927 ||| POS
.  ||| S:927 E:929 ||| .
Multivariable  ||| S:929 E:943 ||| NNP
Cox  ||| S:943 E:947 ||| NNP
regression  ||| S:947 E:958 ||| JJ
analysis  ||| S:958 E:967 ||| NN
was  ||| S:967 E:971 ||| VBD
adjusted  ||| S:971 E:980 ||| VBN
for  ||| S:980 E:984 ||| IN
patient  ||| S:984 E:992 ||| NN
and  ||| S:992 E:996 ||| CC
systemic  ||| S:996 E:1005 ||| JJ
treatment  ||| S:1005 E:1015 ||| NN
characteristics ||| S:1015 E:1030 ||| NNS
.  ||| S:1030 E:1032 ||| .
A  ||| S:1032 E:1034 ||| DT
total  ||| S:1034 E:1040 ||| NN
of  ||| S:1040 E:1043 ||| IN
11,695  ||| S:1043 E:1050 ||| CD
patients  ||| S:1050 E:1059 ||| NNS
were  ||| S:1059 E:1064 ||| VBD
included  ||| S:1064 E:1073 ||| VBN
of  ||| S:1073 E:1076 ||| IN
which  ||| S:1076 E:1082 ||| WDT
2156  ||| S:1082 E:1087 ||| CD
( ||| S:1087 E:1088 ||| -LRB-
18.4 ||| S:1088 E:1092 ||| CD
% ||| S:1092 E:1093 ||| NN
)  ||| S:1093 E:1095 ||| -RRB-
underwent  ||| S:1095 E:1105 ||| VBD
re-excision ||| S:1105 E:1116 ||| JJ
.  ||| S:1116 E:1118 ||| .
Median  ||| S:1118 E:1125 ||| JJ
time  ||| S:1125 E:1130 ||| NN
of  ||| S:1130 E:1133 ||| IN
follow-up  ||| S:1133 E:1143 ||| NNP
was  ||| S:1143 E:1147 ||| VBD
61months  ||| S:1147 E:1156 ||| CD
( ||| S:1156 E:1157 ||| -LRB-
interquartile  ||| S:1157 E:1171 ||| JJ
range  ||| S:1171 E:1177 ||| NN
( ||| S:1177 E:1178 ||| -LRB-
IQR ||| S:1178 E:1181 ||| NNP
)  ||| S:1181 E:1183 ||| -RRB-
26-101 ||| S:1183 E:1189 ||| CD
) ||| S:1189 E:1190 ||| -RRB-
.  ||| S:1190 E:1192 ||| .
The  ||| S:1192 E:1196 ||| DT
5-year  ||| S:1196 E:1203 ||| JJ
overall  ||| S:1203 E:1211 ||| JJ
survival  ||| S:1211 E:1220 ||| NN
rates  ||| S:1220 E:1226 ||| NNS
in  ||| S:1226 E:1229 ||| IN
the  ||| S:1229 E:1233 ||| DT
' ||| S:1233 E:1234 ||| POS
primary  ||| S:1234 E:1242 ||| JJ
BCS  ||| S:1242 E:1246 ||| NNP
only ||| S:1246 E:1250 ||| RB
' ||| S:1250 E:1251 ||| POS
,  ||| S:1251 E:1253 ||| ,
' ||| S:1253 E:1254 ||| ''
re-excision  ||| S:1254 E:1266 ||| JJ
by  ||| S:1266 E:1269 ||| IN
BCS ||| S:1269 E:1272 ||| NNP
'  ||| S:1272 E:1274 ||| POS
and  ||| S:1274 E:1278 ||| NN
' ||| S:1278 E:1279 ||| POS
re-excision  ||| S:1279 E:1291 ||| JJ
by  ||| S:1291 E:1294 ||| IN
mastectomy ||| S:1294 E:1304 ||| NN
'  ||| S:1304 E:1306 ||| POS
group  ||| S:1306 E:1312 ||| NN
were  ||| S:1312 E:1317 ||| VBD
92 ||| S:1317 E:1319 ||| CD
% ||| S:1319 E:1320 ||| NN
,  ||| S:1320 E:1322 ||| ,
95 ||| S:1322 E:1324 ||| CD
%  ||| S:1324 E:1326 ||| NN
and  ||| S:1326 E:1330 ||| CC
91 ||| S:1330 E:1332 ||| CD
% ||| S:1332 E:1333 ||| NN
,  ||| S:1333 E:1335 ||| ,
respectively ||| S:1335 E:1347 ||| RB
.  ||| S:1347 E:1349 ||| .
The  ||| S:1349 E:1353 ||| DT
10-year  ||| S:1353 E:1361 ||| JJ
overall  ||| S:1361 E:1369 ||| JJ
survival  ||| S:1369 E:1378 ||| NN
rates  ||| S:1378 E:1384 ||| NNS
were  ||| S:1384 E:1389 ||| VBD
81 ||| S:1389 E:1391 ||| CD
% ||| S:1391 E:1392 ||| NN
,  ||| S:1392 E:1394 ||| ,
82 ||| S:1394 E:1396 ||| CD
%  ||| S:1396 E:1398 ||| NN
and  ||| S:1398 E:1402 ||| CC
79 ||| S:1402 E:1404 ||| CD
% ||| S:1404 E:1405 ||| NN
,  ||| S:1405 E:1407 ||| ,
respectively  ||| S:1407 E:1420 ||| RB
( ||| S:1420 E:1421 ||| -LRB-
P=0.20 ||| S:1421 E:1427 ||| NNP
) ||| S:1427 E:1428 ||| -RRB-
.  ||| S:1428 E:1430 ||| .
After  ||| S:1430 E:1436 ||| IN
multivariable  ||| S:1436 E:1450 ||| JJ
analyses  ||| S:1450 E:1459 ||| NNS
no  ||| S:1459 E:1462 ||| DT
significant  ||| S:1462 E:1474 ||| JJ
association  ||| S:1474 E:1486 ||| NN
was  ||| S:1486 E:1490 ||| VBD
observed  ||| S:1490 E:1499 ||| VBN
between  ||| S:1499 E:1507 ||| IN
use  ||| S:1507 E:1511 ||| NN
of  ||| S:1511 E:1514 ||| IN
and  ||| S:1514 E:1518 ||| CC
type  ||| S:1518 E:1523 ||| NN
of  ||| S:1523 E:1526 ||| IN
re-excision  ||| S:1526 E:1538 ||| JJ
and  ||| S:1538 E:1542 ||| CC
overall  ||| S:1542 E:1550 ||| JJ
survival ||| S:1550 E:1558 ||| NN
.  ||| S:1558 E:1560 ||| .
The  ||| S:1560 E:1564 ||| DT
overall  ||| S:1564 E:1572 ||| JJ
survival  ||| S:1572 E:1581 ||| NN
of  ||| S:1581 E:1584 ||| IN
breast  ||| S:1584 E:1591 ||| JJ
cancer  ||| S:1591 E:1598 ||| NN
patients  ||| S:1598 E:1607 ||| NNS
with  ||| S:1607 E:1612 ||| IN
a  ||| S:1612 E:1614 ||| DT
re-excision  ||| S:1614 E:1626 ||| NN
did  ||| S:1626 E:1630 ||| VBD
not  ||| S:1630 E:1634 ||| RB
significantly  ||| S:1634 E:1648 ||| RB
differ  ||| S:1648 E:1655 ||| VB
from  ||| S:1655 E:1660 ||| IN
the  ||| S:1660 E:1664 ||| DT
survival  ||| S:1664 E:1673 ||| NN
of  ||| S:1673 E:1676 ||| IN
women  ||| S:1676 E:1682 ||| NNS
who  ||| S:1682 E:1686 ||| WP
underwent  ||| S:1686 E:1696 ||| VBD
primary  ||| S:1696 E:1704 ||| JJ
BCS  ||| S:1704 E:1708 ||| NNP
only ||| S:1708 E:1712 ||| RB
.  ||| S:1712 E:1714 ||| .
Advising  ||| S:1714 E:1723 ||| VBG
re-excision  ||| S:1723 E:1735 ||| JJ
only  ||| S:1735 E:1740 ||| JJ
for  ||| S:1740 E:1744 ||| IN
those  ||| S:1744 E:1750 ||| DT
tumours  ||| S:1750 E:1758 ||| JJ
showing  ||| S:1758 E:1766 ||| NN
' ||| S:1766 E:1767 ||| POS
more  ||| S:1767 E:1772 ||| JJR
than  ||| S:1772 E:1777 ||| IN
focally  ||| S:1777 E:1785 ||| JJ
positive ||| S:1785 E:1793 ||| NN
'  ||| S:1793 E:1795 ||| POS
resection  ||| S:1795 E:1805 ||| JJ
margin  ||| S:1805 E:1812 ||| NN
appears  ||| S:1812 E:1820 ||| VBZ
safe ||| S:1820 E:1824 ||| JJ
,  ||| S:1824 E:1826 ||| ,
supposing  ||| S:1826 E:1836 ||| VBG
the  ||| S:1836 E:1840 ||| DT
long-term  ||| S:1840 E:1850 ||| JJ
safety  ||| S:1850 E:1857 ||| NN
of  ||| S:1857 E:1860 ||| IN
the  ||| S:1860 E:1864 ||| DT
recent  ||| S:1864 E:1871 ||| JJ
SSO ||| S:1871 E:1874 ||| NNP
/ ||| S:1874 E:1875 ||| NNP
ASTRO  ||| S:1875 E:1881 ||| NNP
guideline  ||| S:1881 E:1891 ||| NN
that  ||| S:1891 E:1896 ||| IN
more  ||| S:1896 E:1901 ||| RBR
cautiously  ||| S:1901 E:1912 ||| RB
recommended  ||| S:1912 E:1924 ||| VBN
re-excision  ||| S:1924 E:1936 ||| JJ
for  ||| S:1936 E:1940 ||| IN
tumours  ||| S:1940 E:1948 ||| JJ
showing  ||| S:1948 E:1956 ||| NN
' ||| S:1956 E:1957 ||| POS
ink  ||| S:1957 E:1961 ||| NN
on  ||| S:1961 E:1964 ||| IN
tumour ||| S:1964 E:1970 ||| NN
' ||| S:1970 E:1971 ||| POS
.  ||| S:1971 E:1973 ||| .
